| Size | Price | Stock |
|---|---|---|
| 100mg | $28 | In-stock |
| 250mg | $47 | In-stock |
| 1g | $126 | In-stock |
| 5g | $439 | In-stock |
| 10 g | Get quote | |
| 50 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-139109 |
| M.Wt: | 749.35 |
| Formula: | C38H46ClN2NaO6S2 |
| Purity: | >98 % |
| Solubility: | DMSO : 116.67 mg/mL (ultrasonic) |
IR-783 (ADS 780WS) is a heptamethine cyanine dye. IR-783 induces Mitochondrial membrane potential loss, ATP depletion, mitochondrial permeability transition pore opening, Cytochrome c release and Apoptosis in breast cancer cells. IR-783 promotes the translocation of Drp1 from the cytosol to mitochondria. IR-783 increases the expression of mitochondrial fission proteins such as MFF and Fission-1. IR-783 possesses imaging, cancer-targeting and anticancer properties. IR-783 exerts anticancer effects against breast cancer. IR-783 can be used in breast cancer-related research[1].
In Vitro:IR-783 (20-100 μM; 24 h for membrane potential assays) induces intracellular ATP depletion and loss of mitochondrial membrane potential in breast cancer MDA-MB-231 cells[1].
IR-783 (5-120 μM; 6-72 h) selectively inhibits the viability of breast cancer MDA-MB-231 cells in a dose- and time-dependent manner, but exerts no effect on normal hepatocyte LO2 cells[1].
IR-783 (20-100 μM; 24 h) induces apoptosis in breast cancer MDA-MB-231 cells in a dose-dependent manner[1].
In Vivo:IR-783 (20 mg/kg; i.v.; daily; 4 weeks) significantly inhibits MDA-MB-231 xenograft tumour growth (P < .05) via induction of mitochondrial translocation of Drp1 and tumour cell apoptosis, with low observed liver and kidney toxicity[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.